David D Chang

President and CEO, Director, Allogene Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.3M

Companies

Latest trade

Mar 16, 2026

Companies

Allogene Therapeutics, Inc.President and CEO, Director −$0.3M

Trades

ALLO Sold 47,763 shares at $2.47 $0.1M Mar 16

ALLO Sold 95,269 shares at $1.80 $0.2M Feb 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.